• No results found

Interleukin-1 Receptor Type 1

Mass Spectrometric Analysis of the Endogenous Type I Interleukin 1 (IL 1) Receptor Signaling Complex Formed after IL 1 Binding Identifies IL 1RAcP, MyD88, and IRAK 4 as the Stable Components

Mass Spectrometric Analysis of the Endogenous Type I Interleukin 1 (IL 1) Receptor Signaling Complex Formed after IL 1 Binding Identifies IL 1RAcP, MyD88, and IRAK 4 as the Stable Components

... IL-1 receptor was not ...the receptor complex. Both proteins bound rap- idly to the receptor upon IL-1 stimulation and remained asso- ciated with the complex for at least 1 ...

9

The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface.

The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface.

... factor receptor (EGF-R), which expresses the human EGF-R, were gifts of Jacalyn Pierce (National Cancer Institute, Bethesda, ...erythropoietin receptor (Epo-R) as well as the 11-88 antibody specific for ...

7

Lack of interleukin-1 type 1 receptor enhances the accumulation of mutant huntingtin in the striatum and exacerbates the neurological phenotypes of Huntington's disease mice

Lack of interleukin-1 type 1 receptor enhances the accumulation of mutant huntingtin in the striatum and exacerbates the neurological phenotypes of Huntington's disease mice

... Mouse brain regions were carefully dissected from one hemisphere for western blot analysis, and another hemi- sphere was frozen in O.C.T. on dry ice for cryosectioning. Sagittal sections were cut at 15 μm thickness using ...

7

Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells.

Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells.

... Expression of the type 1 human immunodeficiency virus nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA.. Binding of a nuclear protein to the cycl[r] ...

7

An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1

An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1

... Based on RNA hybrid predictions (45), the ⬃ 2-kbp IL1R1 3= UTR contains two strong seed match sites ( ⱖ 7mer1A) for miR-BHRF1-2-5p and a single site (nt 2 to 7 match) for miR-BHRF1-2-3p. LCL PAR-CLIP studies captured a ...

17

Rational Design and Construction of a Knock-Out Vector for Targeting the Decoy Type 2 Interleukin -1 Receptor

Rational Design and Construction of a Knock-Out Vector for Targeting the Decoy Type 2 Interleukin -1 Receptor

... for type 2 interleukin -1 receptor (Il1r2-/-) in mouse strains and based on the decoy role of the gene product (IL-1R2), we hypothesized that IL-1R2 may have a unique but similar inhibitory ...

9

Determination of Changes in Blood Biomarker Levels in Antipsychotic Polypharmacy and Aripiprazole Monotherapy in Patients With Long-term Schizophrenia

Determination of Changes in Blood Biomarker Levels in Antipsychotic Polypharmacy and Aripiprazole Monotherapy in Patients With Long-term Schizophrenia

... as Interleukin 2 (IL-2) and Inter- leukin 6 (IL-6) are altered in the serum of schizophrenic patients with an upstream regulation of inflammatory cytokines and some of their receptors, such as anti-in- flammatory ...

8

Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma

Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma

... All chemical reagents were purchased from Sigma-Aldrich (St Louis, MO, USA). The IRAK1/4 inhibitor, which se- lectively inhibits the kinase activity of IRAK1 at the IC50 of 0.75 mM and prevents TRAF6-mediated canonical ...

10

Clinical significance of serum 2,5-oligoadenylate synthetase and soluble interleukin-2 receptor in hemophiliacs positive and negative for human immunodeficiency virus type 1.

Clinical significance of serum 2,5-oligoadenylate synthetase and soluble interleukin-2 receptor in hemophiliacs positive and negative for human immunodeficiency virus type 1.

... We measured serum 2,5-oligoadenylate synthetase (2,5-AS) levels and soluble interleukin-2 receptor (sIL-2R) levels in human immune deficiency virus type 1 (HIV-1)-positive and HIV-1-nega[r] ...

5

Role of Interleukin 1 Alpha (IL 1α) and Interleukin 1 Receptor Antagonist (IL 1RA) in Pathogenesis of Juvenile Idiopathic Arthritis and Adult Onset Rheumatoid Arthritis of Iraqi Patients

Role of Interleukin 1 Alpha (IL 1α) and Interleukin 1 Receptor Antagonist (IL 1RA) in Pathogenesis of Juvenile Idiopathic Arthritis and Adult Onset Rheumatoid Arthritis of Iraqi Patients

... the type of administrated therapy. Such IL-1 family cytokine is produced locally in response to infection or inflammation by various tissues, and is observed with high levels in the circulation secondary to ...

7

MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling

MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling

... Toll receptor was determined to play a function in innate immune protection against fungal ...As Type I integral membrane glycoproteins, TLRs share significant cytoplasmic region homology with ...

17

Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIED

Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIED

... Figure 2. Expression of IL1R2 in cochlear implant recipients. 2A Diagram of IL1R2 mRNA depicting regions detected by microarray probes and Q-RT-PCR primers. At position 1117, an alternate splice site has been described ...

10

Age-Dependent Levels of Select Immunological Mediators in Sera of Healthy Children

Age-Dependent Levels of Select Immunological Mediators in Sera of Healthy Children

... years). Interleukin-1 receptor antagonist (IL-1RA), soluble IL-2R (sIL-2R) (sCD25), IL-6, IL-8, tumor necrosis factor alpha (TNF- a ), soluble TNF receptor type II (sTNF-RII) (sCD120b), ...

5

Polymorphisms rs1800795 of interleukin-6 and rs2228145 of interleukin-6 receptor genes in Euro-Brazilians with adult-onset type 1 diabetes mellitus

Polymorphisms rs1800795 of interleukin-6 and rs2228145 of interleukin-6 receptor genes in Euro-Brazilians with adult-onset type 1 diabetes mellitus

... membrane receptor (IL-6R, Chr1, 1q21.3; OMIM 147880) or soluble receptor (sIL-6R), and the complex IL-6–IL-6R or IL-6–sIL-6R couples with gp130 protein to trigger intracellular signaling (Mihara et ...

10

Knockdown of interleukin-10 induces the redistribution of sigma1-receptor and increases the glutamate-dependent NADPH-oxidase activity in mouse brain neurons

Knockdown of interleukin-10 induces the redistribution of sigma1-receptor and increases the glutamate-dependent NADPH-oxidase activity in mouse brain neurons

... sigma receptor-1 (SigR1) is not changed ...substrate 1), NR2B subunit of NMDA-receptor (NMDAR) and inositol-3-phosphate receptor (IP3R) is higher in the IL-10 KO mice brain than in the ...

5

Production of interleukin 1 receptor antagonist by human articular chondrocytes

Production of interleukin 1 receptor antagonist by human articular chondrocytes

... The expression of these various isoforms is cell-type specific and stimulus specific (see [6] for a review). In mice, sIL-1Ra is found predominantly in peripheral blood cells, the lungs, the spleen and the liver ...

8

Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes

Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes

... Figure 1. Expression of IL-1Ra in hearts explanted from patients with end stage ischemic heart disease. (a) Immunofluorescence co- staining for IL-1Ra and PECAM-1. Several cardiomyocytes show positive ...

11

Common TNF α, IL 1β, PAI 1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis

Common TNF α, IL 1β, PAI 1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis

... surface receptor CD14 and interacts with the toll-like receptor 4 (TLR4) to induce nuclear fac- tor κ-B signalling and transcription of cytokines, chemok- ines, adhesion and coagulation factors ...and ...

7

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

... with type 2 diabetes mellitus improves β-cell function ...IL-1RI receptor domains, whereas the Ilantide sequence motif includes only two residues from the binding site that is involved in the interaction ...

18

Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury

Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury

... brain trauma) or after the blood-brain barrier (BBB) breakdown that occurs following brain injury [53]. Evi- dence, both in vivo [46,54,55] and in vitro [56,57] indicate that high levels of thrombin within brain ...

11

Show all 10000 documents...

Related subjects